On Friday, Viking Therapeutics Inc (NASDAQ: VKTX) opened lower -3.18% from the last session, before settling in for the closing price of $40.60. Price fluctuations for VKTX have ranged from $19.15 to $99.41 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -4.65% at the time writing. With a float of $107.97 million, this company’s outstanding shares have now reached $111.43 million.
Let’s look at the performance matrix of the company that is accounted for 27 employees. In terms of profitability, gross margin is 28.9%, operating margin of -30726.61%, and the pretax margin is -22741.06%.
Viking Therapeutics Inc (VKTX) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Viking Therapeutics Inc is 3.04%, while institutional ownership is 73.77%. The most recent insider transaction that took place on Jan 06 ’25, was worth 8,313,601. In this transaction President & CEO of this company sold 194,490 shares at a rate of $42.75, taking the stock ownership to the 2,366,570 shares. Before that another transaction happened on Jan 06 ’25, when Company’s Chief Operating Officer sold 54,215 for $42.75, making the entire transaction worth $2,317,599. This insider now owns 374,134 shares in total.
Viking Therapeutics Inc (VKTX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -4.65% per share during the next fiscal year.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Check out the current performance indicators for Viking Therapeutics Inc (VKTX). In the past quarter, the stock posted a quick ratio of 36.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.94, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -1.49 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
Viking Therapeutics Inc (NASDAQ: VKTX) saw its 5-day average volume 2.35 million, a positive change from its year-to-date volume of 2.24 million. As of the previous 9 days, the stock’s Stochastic %D was 28.71%. Additionally, its Average True Range was 2.44.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 3.44%, which indicates a significant decrease from 14.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.02% in the past 14 days, which was lower than the 79.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $51.62, while its 200-day Moving Average is $60.14. Nevertheless, the first resistance level for the watch stands at $40.20 in the near term. At $41.08, the stock is likely to face the second major resistance level. The third major resistance level sits at $42.01. If the price goes on to break the first support level at $38.39, it is likely to go to the next support level at $37.46. Assuming the price breaks the second support level, the third support level stands at $36.58.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
There are currently 111,436K shares outstanding in the company with a market cap of 4.38 billion. Presently, the company’s annual sales total 0 K according to its annual income of -85,900 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -24,940 K.
